FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:622-623 August 23, 2001 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: High-molecular-weight hydroxyethyl starches (hetastarches) can cause acquired type I von Willebrand's disease.¹ A case has also occurred after treatment with medium-molecular-weight hydroxyethyl starches (pentastarches).² We analyzed all patients with hemostatic disorders that occurred during treatment with pentastarch (Elohes and Hesteril, Fresenius, Paris; and Lomol, Dupont, Wilmington, Del.) and that were spontaneously reported to the 31 French regional drug-monitoring centers.

Nine cases of hemostatic disorders were reported between 1990 and 1997 (Table 1). All patients were treated with Elohes as hemodilution therapy (for vasospasm secondary to subarachnoid hemorrhage).

View this table: [in this window] [in a new window]   Table 1. Characteristics of Patients with a Hemostatic Disorder.

 
Of . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., Olthoff, D., Jaschinski, U., John, S., Rossaint, R., Welte, T., Schaefer, M., Kern, P., Kuhnt, E., Kiehntopf, M., Hartog, C., Natanson, C., Loeffler, M., Reinhart, K., the German Competence Network Sepsis (SepNet), (2008). Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis. NEJM 358: 125-139 [Abstract] [Full Text]  
• Fenger-Eriksen, C., Anker-Moller, E., Heslop, J., Ingerslev, J., Sorensen, B. (2005). Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 94: 324-329 [Abstract] [Full Text]  
• Haynes, G. R., Neff, T. A., Stocker, R., Spahn, D. R. (2004). Is Hydroxyethyl Starch Safe in Brain Injury? * Response. Anesth. Analg. 99: 620-622 [Full Text]  
• Barron, M. E., Wilkes, M. M., Navickis, R. J. (2004). A Systematic Review of the Comparative Safety of Colloids. Arch Surg 139: 552-563 [Abstract] [Full Text]